NareshReddivallaMD

Pediatric Hematology & Oncology • Mesa, AZ

Physician

Join to view full profile

Dr. Reddivalla is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Reddivalla's full profile

Already have an account?

Office
1432 S Dobson Rd, Suite 107
Mesa, AZ 85202
Phone+1 480-412-4100

Fax+1 480-412-5154

Summary

I am a board certified Pediatric Hematologist/ Oncologist. I specialize in treating children with blood disorder and cancer. My areas of interest for treating leukemia, lymphoma, neuroblastoma, bone and soft tissue tumors. I also like treating patient abnormal blood counts, bleeding and clotting disorders. We at Banner Children's provide comprehensive team based approach to treat cancer in children.

Dr. Naresh Reddivalla, MD - Mesa, AZ - Pediatric Hematology, Pediatric Medical O

Find information about and book an appointment with Dr. Naresh Reddivalla, MD in Mesa, AZ, Glendale, AZ, Tucson, AZ. Specialties: Pediatric Hematology, Pediatri

Education & Training

Children’s Mercy HospitalFellowship, Pediatric Hematology/Oncology, 2014 - 2017
Lincoln Medical and Mental Health CenterResidency, Pediatrics, 2011 - 2014
Jawaharlal Nehru Medical CollegeClass of 2008

Certifications & Licensure

AZ State Medical License 2016 - 2027
MO State Medical License 2014 - 2018
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

• John Caffey Award for Best Scientific Exhibit at Society for Pediatric Radiology for “Sinusoidal Obstruction Syndrome Causes Increased Liver Stiffness’’ at 60th annual meeting in Vancouver, British
•First place, 2017 Fellow Research Award at Children’s Mercy Hospital for “Ki-67 proliferative index as a prognostic marker for therapeutic response among pediatric ALL patients"